2633 — Jacobson Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual balance sheet for Jacobson Pharma, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	480	479	1,036	412	509
Net Total Accounts Receivable
Net Total Receivables	281	334	301	188	157
Total Inventory
Total Other Current Assets
Total Current Assets	1,161	1,178	1,757	964	1,038
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,551	1,504	1,502	1,301	1,494
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	4,867	4,756	5,380	3,487	3,645
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	874	826	656	373	553
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	2,477	2,264	2,644	1,115	1,192
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	2,390	2,491	2,737	2,372	2,453
Total Liabilities & Shareholders' Equity	4,867	4,756	5,380	3,487	3,645
Total Common Shares Outstanding